Applied Issuance Repayment of Debt Securities vs Issuance Purchase of Equity Shares Analysis

APDN Stock  USD 0.43  0.01  2.27%   
Trend analysis of Applied DNA Sciences balance sheet accounts such as Total Stockholder Equity of 6 M, Accounts Payable of 921.1 K or Common Stock Total Equity of 4.4 K provides information on Applied DNA's total assets, liabilities, and equity, which is the actual value of Applied DNA Sciences to its prevalent stockholders. By breaking down trends over time using Applied DNA balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

About Applied Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Applied DNA Sciences at a specified time, usually calculated after every quarter, six months, or one year. Applied DNA Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Applied DNA and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Applied currently owns. An asset can also be divided into two categories, current and non-current.

Applied DNA Balance Sheet Chart

Applied DNA Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Applied DNA Sciences uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Applied DNA's Other Current Liabilities is very stable compared to the past year. As of the 28th of March 2024, Total Assets is likely to grow to about 16.5 M, though Retained Earnings are likely to grow to (258.6 M).

Total Current Liabilities

Total Current Liabilities is an item on Applied DNA balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Applied DNA Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Applied DNA obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Applied DNA Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from Applied DNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
As of the 28th of March 2024, Selling General Administrative is likely to drop to about 10 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 10.3 M
 2021 2022 2023 2024 (projected)
Total Revenue18.2M13.4M15.4M16.1M
Research Development3.9M3.7M4.3M4.5M

Applied DNA fundamental ratios Correlations

0.43-0.710.77-0.530.460.390.720.73-0.530.670.69-0.440.590.590.580.410.560.530.580.580.340.390.48-0.460.32
0.43-0.430.65-0.20.290.110.430.27-0.20.750.87-0.850.760.760.90.040.480.320.680.540.010.480.36-0.650.69
-0.71-0.43-0.680.26-0.54-0.5-0.93-0.670.26-0.7-0.650.46-0.57-0.57-0.57-0.51-0.57-0.61-0.68-0.64-0.13-0.17-0.550.63-0.17
0.770.65-0.68-0.340.370.180.610.48-0.340.710.73-0.60.620.620.750.20.440.460.670.660.120.340.43-0.40.48
-0.53-0.20.26-0.34-0.31-0.14-0.29-0.341.0-0.43-0.320.05-0.15-0.15-0.220.26-0.39-0.08-0.44-0.3-0.22-0.28-0.290.35-0.22
0.460.29-0.540.37-0.310.880.740.85-0.30.680.64-0.460.640.640.35-0.090.820.110.820.87-0.380.240.99-0.34-0.26
0.390.11-0.50.18-0.140.880.690.91-0.130.60.55-0.410.60.60.280.00.710.230.650.62-0.240.220.86-0.29-0.3
0.720.43-0.930.61-0.290.740.690.8-0.290.720.72-0.460.630.630.510.440.760.520.770.750.00.290.74-0.650.08
0.730.27-0.670.48-0.340.850.910.8-0.330.730.7-0.50.70.70.470.150.770.410.730.71-0.020.330.84-0.39-0.09
-0.53-0.20.26-0.341.0-0.3-0.13-0.29-0.33-0.42-0.310.04-0.14-0.14-0.210.26-0.38-0.08-0.43-0.29-0.23-0.28-0.280.35-0.22
0.670.75-0.70.71-0.430.680.60.720.73-0.420.93-0.850.90.90.860.020.660.380.890.75-0.090.380.71-0.620.32
0.690.87-0.650.73-0.320.640.550.720.7-0.310.93-0.880.920.920.90.110.740.440.870.76-0.010.520.69-0.680.46
-0.44-0.850.46-0.60.05-0.46-0.41-0.46-0.50.04-0.85-0.88-0.96-0.96-0.93-0.02-0.39-0.35-0.68-0.630.18-0.21-0.520.41-0.35
0.590.76-0.570.62-0.150.640.60.630.7-0.140.90.92-0.961.00.880.110.550.40.750.74-0.210.250.68-0.420.2
0.590.76-0.570.62-0.150.640.60.630.7-0.140.90.92-0.961.00.880.110.550.40.750.74-0.210.250.68-0.420.2
0.580.9-0.570.75-0.220.350.280.510.47-0.210.860.9-0.930.880.880.070.40.450.690.590.090.320.42-0.560.58
0.410.04-0.510.20.26-0.090.00.440.150.260.020.11-0.020.110.110.070.070.46-0.12-0.020.180.05-0.11-0.160.04
0.560.48-0.570.44-0.390.820.710.760.77-0.380.660.74-0.390.550.550.40.070.290.810.71-0.120.710.82-0.630.14
0.530.32-0.610.46-0.080.110.230.520.41-0.080.380.44-0.350.40.40.450.460.290.320.270.220.160.15-0.40.27
0.580.68-0.680.67-0.440.820.650.770.73-0.430.890.87-0.680.750.750.69-0.120.810.320.89-0.130.420.86-0.680.27
0.580.54-0.640.66-0.30.870.620.750.71-0.290.750.76-0.630.740.740.59-0.020.710.270.89-0.290.160.91-0.420.0
0.340.01-0.130.12-0.22-0.38-0.240.0-0.02-0.23-0.09-0.010.18-0.21-0.210.090.18-0.120.22-0.13-0.290.17-0.37-0.350.56
0.390.48-0.170.34-0.280.240.220.290.33-0.280.380.52-0.210.250.250.320.050.710.160.420.160.170.25-0.540.55
0.480.36-0.550.43-0.290.990.860.740.84-0.280.710.69-0.520.680.680.42-0.110.820.150.860.91-0.370.25-0.39-0.18
-0.46-0.650.63-0.40.35-0.34-0.29-0.65-0.390.35-0.62-0.680.41-0.42-0.42-0.56-0.16-0.63-0.4-0.68-0.42-0.35-0.54-0.39-0.61
0.320.69-0.170.48-0.22-0.26-0.30.08-0.09-0.220.320.46-0.350.20.20.580.040.140.270.270.00.560.55-0.18-0.61
Click cells to compare fundamentals

Applied DNA Account Relationship Matchups

Applied DNA fundamental ratios Accounts

201920202021202220232024 (projected)
Total Current Liabilities4.3M3.3M4.2M2.8M3.3M3.9M
Total Stockholder Equity5.7M11.1M12.9M5.0M5.7M6.0M
Retained Earnings(269.8M)(284.1M)(292.5M)(302.4M)(272.2M)(258.6M)
Accounts Payable1.3M2.0M1.7M1.1M1.2M921.1K
Common Stock Shares Outstanding3.9M6.9M9.0M13.1M15.0M15.8M
Non Current Liabilities Total1.4M31.5K5.2M5.9M6.8M7.2M
Other Stockholder Equity275.5M295.2M305.4M307.4M353.5M371.2M
Total Liab5.6M3.3M9.4M8.8M10.1M10.6M
Common Stock5.1K7.5K12.9K13.7K12.3K11.7K
Other Current Liab676.4K980.9K1.9M1.2M1.1M1.1M
Total Assets11.3M14.4M22.3M13.7M15.7M16.5M
Net Debt(5.4M)(6.6M)(15.2M)(5.9M)(5.3M)(5.1M)
Cash7.8M6.6M15.2M7.2M8.2M8.6M
Cash And Short Term Investments7.8M6.6M15.2M7.2M8.2M8.6M
Liabilities And Stockholders Equity11.3M14.4M22.3M13.7M15.7M16.5M
Total Current Assets9.1M11.3M19.9M8.1M9.3M5.0M
Non Current Assets Total2.3M3.1M2.3M5.5M6.4M6.7M
Intangible Assets864.2K734.8K605.3K2.7M2.4M2.6M
Property Plant And Equipment Net1.3M3.0M2.2M2.1M2.4M2.5M
Current Deferred Revenue511.0K281K563.6K76.4K68.8K65.4K
Non Currrent Assets Other95.1K95.0K99.0K750K862.5K905.6K
Property Plant And Equipment Gross1.3M3.8M4.3M5.5M6.3M6.6M
Net Receivables194.3K2.8M3.1M255.5K293.8K279.1K
Other Current Assets599.3K568.9K1.1M389.2K447.6K373.6K
Net Tangible Assets(1.9M)4.8M11.1M12.9M14.8M15.6M
Property Plant Equipment226.2K1.3M3.0M2.2M2.6M2.7M
Other Assets172.0K95.1K95.0K99.0K89.1K84.6K
Inventory497.4K1.4M602.2K330.0K379.5K347.2K
Other Liab622.0K848.3K31.5K5.2M5.9M6.2M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Applied DNA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Applied DNA's short interest history, or implied volatility extrapolated from Applied DNA options trading.

Pair Trading with Applied DNA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.

Moving together with Applied Stock

  0.71KN Knowles Cor Financial Report 25th of April 2024 PairCorr
  0.71UI Ubiquiti Networks Financial Report 3rd of May 2024 PairCorr

Moving against Applied Stock

  0.81NTAP NetApp Inc Financial Report 29th of May 2024 PairCorr
  0.69MINM Minim Inc Report 3rd of April 2024 PairCorr
  0.57CDW CDW Corp Financial Report 1st of May 2024 PairCorr
  0.56GLW Corning Incorporated Financial Report 23rd of April 2024 PairCorr
  0.51NNDM Nano Dimension Report 4th of April 2024 PairCorr
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Applied Stock analysis

When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.55)
Revenue Per Share
0.678
Quarterly Revenue Growth
(0.83)
Return On Assets
(0.56)
Return On Equity
(1.10)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.